Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A
暂无分享,去创建一个
Cheng Luo | Jingkang Shen | Suxin Zheng | Xu Shen | Rolf Hilgenfeld | Gang Pei | Kaixian Chen | Jing Chen | Jianhua Shen | Xiaomin Luo | Hualiang Jiang | Xiaomin Luo | Kaixian Chen | Hualiang Jiang | Jianhua Shen | Xu Shen | Hong Liu | Jingkang Shen | Suxin Zheng | C. Gui | R. Hilgenfeld | Haibin Luo | C. Luo | Tao Sun | Jing-kang Shen | Jing Chen | G. Pei | Hong Liu | Liduo Yue | Yiming Yang | Haibin Luo | Chunshan Gui | Donglu Bai | D. Bai | Tao Sun | Changying Yu | Peilan He | Yi-Xue Li | Fangqiu Li | Jianping Zuo | Liduo Yue | Jianping Zuo | Yiming Yang | Changying Yu | Peilan He | Yixue Li | Fangqiu Li
[1] D. Speicher,et al. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. , 1984, Science.
[2] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[3] K. Sharp,et al. Electrostatic interactions in macromolecules: theory and applications. , 1990, Annual review of biophysics and biophysical chemistry.
[4] Krishna Shankara Narayanan,et al. Nucleocapsid-Independent Specific Viral RNA Packaging via Viral Envelope Protein and Viral RNA Signal , 2003, Journal of Virology.
[5] P. Kollman,et al. Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models. , 2000, Journal of medicinal chemistry.
[6] Ioannis Xenarios,et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions , 2002, Nucleic Acids Res..
[7] L. Poon,et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .
[8] W. Sundquist,et al. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. , 1997, Journal of molecular biology.
[9] M. Chan-yeung,et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.
[10] Arthur S Slutsky,et al. Identification of severe acute respiratory syndrome in Canada. , 2003, The New England journal of medicine.
[11] Christian Drosten,et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[12] D. A. Dougherty,et al. Cation-π interactions in structural biology , 1999 .
[13] W. Sundquist,et al. Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid , 1996, Cell.
[14] J Sühnel,et al. More Hydrogen Bonds for the (structural) Biologist , 2022 .
[15] Hz.. Glycyrrhizin , 2022 .
[16] Rodrigo Lopez,et al. Multiple sequence alignment with the Clustal series of programs , 2003, Nucleic Acids Res..
[17] J. Sühnel,et al. C-h⋯π-interactions in proteins , 2001 .
[18] Xiaolei Yin,et al. Expression cloning of functional receptor used by SARS coronavirus , 2004, Biochemical and Biophysical Research Communications.
[19] Jing Chen,et al. Small envelope protein E of SARS: cloning, expression, purification, CD determination, and bioinformatics analysis. , 2003, Acta pharmacologica Sinica.
[20] B. Hogue. Bovine coronavirus nucleocapsid protein processing and assembly. , 1995, Advances in experimental medicine and biology.
[21] J. Tözsér,et al. Effect of cyclosporin A on the replication cycle of human immunodeficiency virus type 1 derived from H9 and Molt-4 producer cells. , 1996, The Journal of general virology.
[22] J. Luban,et al. Cyclophilin A regulates HIV‐1 infectivity, as demonstrated by gene targeting in human T cells , 2001, The EMBO journal.
[23] Christian Drosten,et al. Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.
[24] Cheng Luo,et al. A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. , 2003, Acta pharmacologica Sinica.
[25] S. Moyer,et al. An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function in viral RNA synthesis , 1997, Journal of virology.
[26] M. Lowdell,et al. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] Andreas Koeller,et al. Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design. , 2004, Journal of medicinal chemistry.
[28] Peter Cameron,et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.
[29] Yuan WANG,et al. Identification of an epitope of SARS-coronavirus nucleocapsid protein , 2003, Cell Research.
[30] Obi L. Griffith,et al. The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.
[31] J. A. Comer,et al. A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[32] Rolf Hilgenfeld,et al. Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs , 2003, Science.
[33] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[34] A. Velázquez‐Campoy,et al. Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. , 2004, Biochemistry.
[35] John L. Sullivan,et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.
[36] L. Nilsson,et al. Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K , 2001 .
[37] Michael R. Green,et al. A human nucleoporin-like protein that specifically interacts with HIV Rev , 1995, Nature.
[38] H. Perreault,et al. Mass Spectrometric Characterization of Proteins from the SARS Virus , 2003, Molecular & Cellular Proteomics.
[39] D. A. Dougherty,et al. Cation-pi interactions in structural biology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] Leszek Rychlewski,et al. mRNA Cap-1 Methyltransferase in the SARS Genome , 2003, Cell.
[41] R M Esnouf,et al. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.
[42] Krishna Shankara Narayanan,et al. Characterization of the Coronavirus M Protein and Nucleocapsid Interaction in Infected Cells , 2000, Journal of Virology.
[43] Jeremy Luban,et al. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.
[44] W. Sundquist,et al. Structural insights into the catalytic mechanism of cyclophilin A , 2003, Nature Structural Biology.
[45] M. Wainberg,et al. The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. , 1988, Blood.
[46] H. Doerr,et al. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus , 2003, The Lancet.
[47] G. Gao,et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor , 2003, Proceedings of the National Academy of Sciences of the United States of America.